Constellation Pharmaceuticals Inc (CNST):企業の財務・戦略的SWOT分析

◆英語タイトル:Constellation Pharmaceuticals Inc (CNST) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1635
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Constellation Pharmaceuticals Inc (CNST) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Constellation Pharmaceuticals Inc (Constellation) is a clinical biopharmaceutical company that focuses to develop novel therapeutics for the treatment of serious unmet medical needs in patients with cancers associated with abnormal gene expression. The company’s pipeline products include CPI-1205 for the treatment of metastatic castration-resistant prostate cancer (mCRPC); CPI-0610 for the treatment of patients with myelofibrosis (MF) and CPI-0209 for solid tumors and/or hematological malignancies. It utilizes integrated epigenetics platform that enables it to validate targets and generate small molecules against the targets that modulate gene expression in tumor and immune cells. Constellation is headquartered in Cambridge, Massachusetts, the US.

Constellation Pharmaceuticals Inc Key Recent Developments

Apr 06,2020 Constellation Pharmaceuticals announces appointment of Dr. Richard Levy to board of directors
Mar 10,2020 Constellation Pharmaceuticals announces fourth-quarter and full-year 2019 financial results
Nov 06,2019 Constellation Pharmaceuticals announces third-quarter and nine-month 2019 financial results
Aug 07,2019 Constellation Pharmaceuticals announces second-quarter and six-month 2019 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Constellation Pharmaceuticals Inc – Key Facts
Constellation Pharmaceuticals Inc – Key Employees
Constellation Pharmaceuticals Inc – Key Employee Biographies
Constellation Pharmaceuticals Inc – Major Products and Services
Constellation Pharmaceuticals Inc – History
Constellation Pharmaceuticals Inc – Company Statement
Constellation Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Constellation Pharmaceuticals Inc – Business Description
Constellation Pharmaceuticals Inc – Corporate Strategy
Constellation Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Constellation Pharmaceuticals Inc – Strengths
Constellation Pharmaceuticals Inc – Weaknesses
Constellation Pharmaceuticals Inc – Opportunities
Constellation Pharmaceuticals Inc – Threats
Constellation Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Constellation Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Constellation Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Constellation Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 06, 2020: Constellation Pharmaceuticals announces appointment of Dr. Richard Levy to board of directors
Mar 10, 2020: Constellation Pharmaceuticals announces fourth-quarter and full-year 2019 financial results
Nov 06, 2019: Constellation Pharmaceuticals announces third-quarter and nine-month 2019 financial results
Aug 07, 2019: Constellation Pharmaceuticals announces second-quarter and six-month 2019 financial results
May 08, 2019: Constellation Pharmaceuticals announces first-quarter 2019 financial results
Mar 14, 2019: Constellation Pharmaceuticals announces fourth-quarter and full-year 2018 financial results
Mar 04, 2019: Constellation Pharmaceuticals names Jessica Christo as chief product development officer
Feb 20, 2019: Constellation Pharmaceuticals announces appointment to Board of Directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Constellation Pharmaceuticals Inc, Key Facts
Constellation Pharmaceuticals Inc, Key Employees
Constellation Pharmaceuticals Inc, Key Employee Biographies
Constellation Pharmaceuticals Inc, Major Products and Services
Constellation Pharmaceuticals Inc, History
Constellation Pharmaceuticals Inc, Subsidiaries
Constellation Pharmaceuticals Inc, Key Competitors
Constellation Pharmaceuticals Inc, Ratios based on current share price
Constellation Pharmaceuticals Inc, Annual Ratios
Constellation Pharmaceuticals Inc, Annual Ratios (Cont...1)
Constellation Pharmaceuticals Inc, Interim Ratios
Constellation Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Constellation Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Constellation Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Constellation Pharmaceuticals Inc, Performance Chart (2016 - 2019)
Constellation Pharmaceuticals Inc, Ratio Charts
Constellation Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Constellation Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Constellation Pharmaceuticals Inc (CNST):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shinko Electric Industries Co., Ltd.:企業の戦略・SWOT・財務情報
    Shinko Electric Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shinko Electric Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Nisshinbo Holdings Inc. (3105):企業の財務・戦略的SWOT分析
    Nisshinbo Holdings Inc. (3105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Just Energy Group Inc. (JE):電力:M&Aディール及び事業提携情報
    Summary Just Energy Group Inc. (Just Energy) is a provider of energy management solutions. The company offers natural gas, electricity, solar energy, green energy and energy efficiency tools and products to customers. It serves consumer and commercial markets through fixed price contracts, variable- …
  • Banner Corp:企業の戦略・SWOT・財務情報
    Banner Corp - Strategy, SWOT and Corporate Finance Report Summary Banner Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Jaya Tiasa Holdings Berhad (JTIASA):企業の財務・戦略的SWOT分析
    Jaya Tiasa Holdings Berhad (JTIASA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Pegatron Corporation:企業の戦略・SWOT・財務情報
    Pegatron Corporation - Strategy, SWOT and Corporate Finance Report Summary Pegatron Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • amcure GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Amcure GmbH (Amcure) is a biopharmaceutical company that discovers and develops therapeutics for the treatment of cancer. The company develops peptide-based compounds for the treatment of metastatic forms of cancer. Its lead candidate, AMC303 is used for the treatment of metastatic epithelia …
  • Maxar Technologies Ltd (MAXR):企業の財務・戦略的SWOT分析
    Maxar Technologies Ltd (MAXR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Strategic Resources Inc. (STI):企業の財務・戦略的SWOT分析
    Strategic Resources Inc. (STI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • AIA Bhd:企業の戦略・SWOT・財務情報
    AIA Bhd - Strategy, SWOT and Corporate Finance Report Summary AIA Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • True Value Company:企業の戦略・SWOT・財務情報
    True Value Company - Strategy, SWOT and Corporate Finance Report Summary True Value Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • VBI Vaccines Inc (VBV):製薬・医療:M&Aディール及び事業提携情報
    Summary VBI Vaccines Inc (VBI), a subsidiary of SciVac Therapeutics Inc is a biopharmaceutical company that discovers and develops novel vaccines for the treatment of immuno-oncology and infectious diseases. The company’s pipeline vaccine candidates include cytomegalovirus; glioblastoma multiforme a …
  • IDT Biologika GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary IDT Biologika GmbH (IDT Biologika), a subsidiary of Klocke Pharma-Service GmbH, is a vaccines and pharmaceuticals manufacturer. The company offers contract manufacturing services. It provides integrated development and manufacturing services in four major areas of animal health, vaccines, ph …
  • Trianni Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Trianni Inc (Trianni) is a developer of fully human monoclonal antibodies that provides its propriety discovery platform. The company provides Trianni Mouse platform that holds engineered versions of three antibody-encoding genetic loci, namely, Heavy, Kappa, Lambda, and others. It enables t …
  • Strongbridge Biopharma plc (SBBP):製薬・医療:M&Aディール及び事業提携情報
    Summary Strongbridge Biopharma Plc (Strongbridge Biopharma), formerly Cortendo Plc is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases. The company’s marketed product KEVEYIS (dichlorphenamide) is indicated for the treatment of hypokalemic, hy …
  • Hemostemix Inc (HEM):製薬・医療:M&Aディール及び事業提携情報
    Summary Hemostemix Inc (Hemostemix), formerly Theravitae Inc, is a biotechnology company that develops, manufactures and commercializes proprietary autologous cell therapy for the treatment of ischemic diseases. The company’s clinical-stage candidate includes ACP-01, an autologous cell therapy for t …
  • East African Breweries Limited:企業の戦略・SWOT・財務情報
    East African Breweries Limited - Strategy, SWOT and Corporate Finance Report Summary East African Breweries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Daito Trust Construction Co., Ltd.:企業の戦略・SWOT・財務情報
    Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • L’Occitane International SA:企業の戦略・SWOT・財務情報
    L'Occitane International SA - Strategy, SWOT and Corporate Finance Report Summary L'Occitane International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Storebrand ASA:戦略・SWOT・企業財務分析
    Storebrand ASA - Strategy, SWOT and Corporate Finance Report Summary Storebrand ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆